Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
J Clin Psychopharmacol ; 34(2): 205-11, 2014 Apr.
Article de Anglais | MEDLINE | ID: mdl-24525640

RÉSUMÉ

Methadone is a synthetic opioid that binds to the κ-opioid receptor with a low affinity. This study tested the hypotheses that the genetic polymorphisms in the κ-opioid receptor 1 (OPRK1) gene region are associated with methadone treatment responses in a Taiwan methadone maintenance treatment (MMT) cohort. Seventeen single nucleotide polymorphisms (SNPs) in OPRK1 were selected and genotyped on DNA of 366 MMT patients. Six SNPs from rs7843965 to rs1051660 (intron 2 to exon 2) were significantly associated with body weight (P < 0.007). A haplotype of 4 SNPs rs7832417-rs16918853-rs702764-rs7817710 (exon 4 to intron 3) was associated with bone or joint aches (P ≤ 0.004) and with the amount of alcohol use (standard drinks per day; global P < 0.0001). The haplotype rs10958350-rs7016778-rs12675595 was associated with gooseflesh skin (global P < 0.0001), yawning (global P = 0.0001), and restlessness (global P < 0.0001) withdrawal symptoms. The findings suggest that genetic polymorphisms in OPRK1 were associated with the body weight, alcohol use, and opioid withdrawal symptoms in MMT patients.


Sujet(s)
Consommation d'alcool/génétique , Poids/génétique , Méthadone/effets indésirables , Méthadone/usage thérapeutique , Traitement de substitution aux opiacés/effets indésirables , Polymorphisme de nucléotide simple/génétique , Récepteur kappa/génétique , Syndrome de sevrage/génétique , Adolescent , Adulte , Études d'associations génétiques , Haplotypes , Dépendance à l'héroïne/traitement médicamenteux , Humains , Méthadone/pharmacocinétique , Taïwan , Jeune adulte
2.
Pharmacogenomics ; 13(8): 879-88, 2012 Jun.
Article de Anglais | MEDLINE | ID: mdl-22676193

RÉSUMÉ

AIM: To test whether the genetic polymorphisms within the gene encoding the UGT2B7 gene may have an impact on methadone treatment. MATERIALS & METHODS: Twelve SNPs in UGT2B7 were selected. 366 methadone maintenance treatment patients in Taiwan were recruited and genotyped. RESULTS: In a genotype recessive model, rs6600879, rs6600880, rs4554144, rs11940316, rs7438135, rs7662029, rs7668258, rs7439366, rs4292394 and rs6600893 showed significant associations with severity of withdrawal symptoms (permutation p < 0.002), pupil size (permutation p < 0.048) and tremor (permutation p < 0.008). Haplotypes of GATCAGCCGC and CTCTGATTCT were significantly associated with pupil size score and tremor score (p < 0.034). CONCLUSION: These results suggest that SNPs of the UGT2B7 gene may play important roles in opiate withdrawal symptoms.


Sujet(s)
Glucuronosyltransferase/génétique , Méthadone , Morphine , Syndrome de sevrage/génétique , Adulte , Amitriptyline/sang , Femelle , Études d'associations génétiques , Haplotypes , Dépendance à l'héroïne/traitement médicamenteux , Dépendance à l'héroïne/génétique , Humains , Déséquilibre de liaison , Mâle , Méthadone/administration et posologie , Méthadone/effets indésirables , Méthadone/sang , Adulte d'âge moyen , Morphine/sang , Morphine/urine , Polymorphisme de nucléotide simple , Pyrrolidines/sang , Syndrome de sevrage/anatomopathologie , Taïwan
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE